The Priority Review

Tag

Nektar Therapeutics

1 story

  1. Clinical trials

    Nektar posts results of Phase 2/3 NKTR-255 trial in relapsed/refractory large B-cell lymphoma

    Results for the study were first posted on ClinicalTrials.gov on October 16, 2026. The terminated study enrolled 15 participants and had a primary completion date of May 22, 2024.